Press release content from Globe Newswire. The AP news staff was not involved in its creation.
The Portability of Aquadex SmartFlow® from CHF Solutions Could Mean More Critically-Ill .
CHF Solutions, Inc.April 8, 2021 GMT
EDEN PRAIRIE, Minn., April 08, 2021 (GLOBE NEWSWIRE) Bringing transportable care directly to patients who are too critically-ill to be moved could be the difference between life and death. New evidence demonstrates that ultrafiltration therapy (aquapheresis) using the Aquadex SmartFlow® system by CHF Solutions may be lifesaving for patients with profound and catastrophic multi-organ failure due to fluid overload, in part due to the device’s flexibility and portability. Aquadex™ gently removes excess fluid from the blood to alleviate burden on key organs such as the kidneys and heart.
CHF Solutions Appoints Nestor Jaramillo, Jr. as President and Chief Executive Officer
January 19, 2021 08:00 ET | Source: CHF Solutions, Inc. CHF Solutions, Inc. Eden Prairie, Minnesota, UNITED STATES
EDEN PRAIRIE, Minn., Jan. 19, 2021 (GLOBE NEWSWIRE) CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the appointment of President and Chief Operating Officer Nestor Jaramillo, Jr. to President and Chief Executive Officer (CEO), effective immediately. Predecessor CEO John Erb will continue to serve as the company’s Chairman of the Board.
Mr. Jaramillo joined CHF Solutions in May 2019 and has driven the evolution of the company’s therapeutic focus strategy from solely heart failure to an expansion into critical care and pediatrics. His vision to transform the trajectory of cardiorenal disease has led to an expansion in use of Aquad